Protecting America’s Life Saving Medicines Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Dec 11, 2019)
Protecting America's Life Saving Medicines Act of 2019
This bill directs the Food and Drug Administration (FDA) to conduct a study on drugs that are currently being tested and are unlikely to be approved, but would, if approved, address an unmet medical need for the treatment of a serious or life threatening disease or condition or a rare disease or condition (high-risk, high-reward drugs). The FDA must submit to the Department of the Treasury a list of such high-risk, high-reward drugs not later than 180 days after the completion of the study.
The bill also allows a new tax credit for 25% of the clinical testing expenses for high-risk, high-reward drugs.
What just happenedDec 12, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseDec 11, 2019
- Dec 12, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Dec 11, 2019IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Dec 11, 2019IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Dec 11, 2019IntroReferralIntro-H
Introduced in House
- Dec 11, 2019IntroReferral1000
Introduced in House